Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PER2 | O15055 | 1/20 | 0.34 |
| ▸ | CRY2 | Q49AN0 | 1/20 | 0.34 |
| ▸ | NOS3 | P29474 | 2/20 | 0.33 |
| ▸ | NOS1 | P29475 | 2/20 | 0.33 |
| ▸ | NOS2 | P35228 | 2/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.33 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.33 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.33 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.33 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.33 |
| ▸ | ACE | P12821 | 4/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6926233 | 0.95 | CHRNB2 (0.39) | PER2CRY2NOS3NOS1NOS2 | |
| SCHEMBL35532 | 0.89 | AR (0.32) | PER2CRY2CHRNB2CHRNA7CHRNA4 | |
| Hydrochloric Acid SCHEMBL30940345 | 0.87 | AR (0.32) | PER2CRY2NOS3NOS1NOS2 | |
| SCHEMBL29076626 | 0.82 | NOS1 (0.41) | NOS1NOS2CHRNB2CHRNA7CHRNA4 | |
| SCHEMBL7238109 | 0.81 | CHRNB2 (0.34) | CHRNB2CHRNA7CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL20136144 | 0.81 | CHRNB2 (0.37) | CHRNB2CHRNA7CHRNA4 | |
| SCHEMBL11317370 | 0.81 | ACHE (0.31) | ACE | |
| SCHEMBL18289478 | 0.80 | ALDH1A1 (0.33) | NOS1NOS2CHRNB2CHRNA7CHRNA4 | |
| SCHEMBL868861 | 0.79 | ALDH1A1 (0.36) | CHRNB2CHRNA7CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL35531 | 0.76 | PIK3CD (0.35) | PER2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108366954-A | Tooth whitening composition comprising a peroxide complex and percarbonate | 高露洁-棕榄公司 | 2018-08-03 | — | — | CN | disclosed |
| CN-107921296-A | Tooth whitening oral care composition | 高露洁-棕榄公司 | 2018-04-17 | — | — | CN | disclosed |
| US-8288496-B2 | Contact lens and its manufacturing method | NIPPON CONTACT LENS INC. (JP) | 2012-10-16 | — | — | US | disclosed |
| US-20110237701-A1 | CONTACT LENS AND ITS MANUFACTURING METHOD | NIPPON CONTACT LENS INC. (JP) | 2011-09-29 | — | — | US | disclosed |
| EP-2369370-A2 | Contact lens and its manufacturing method | Nippon Contact Lens Inc. (JP) | 2011-09-28 | — | — | EP | disclosed |
| US-6583281-B2 | Using phenothiazine | BASF AKTIENGESELLSCHAFT (DE) | 2003-06-24 | — | — | US | disclosed |
| US-20020002280-A1 | Stabilized N-alkenyllactam | BASF AKTIENGESELLSCHAFT (DE) | 2002-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020002280-A1 | Stabilized N-alkenyllactam | ALK, NPM1, MYC | PER2 3541/4885CRY2 2180/4885NOS3 3431/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.